<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>OAR@UM Collection:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/117048</link>
    <description />
    <pubDate>Sun, 07 Jun 2026 17:20:52 GMT</pubDate>
    <dc:date>2026-06-07T17:20:52Z</dc:date>
    <item>
      <title>Role of canonical WNT pathway genes in osteoporosis &amp; fracture risk</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/120171</link>
      <description>Title: Role of canonical WNT pathway genes in osteoporosis &amp; fracture risk
Abstract: Osteoporosis is a multifactorial bone disease characterised by reduced bone mass and &#xD;
microarchitectural deterioration, leading to a high fracture risk. It has a strong genetic &#xD;
component, with several gene variants involved in the disease including those within WNT16, &#xD;
DKK1, and SOST, with all three encoded proteins having crucial roles in the WNT/β-catenin &#xD;
signalling pathway. Downstream to SOST is a distal enhancer element known as ECR5&#xD;
required for SOST transcriptional activity. The study aimed to determine whether gene &#xD;
variants within WNT16, DKK1, and SOST, including SOST ECR5, alter osteoporosis and &#xD;
fracture risk in Malta. A total of eight carefully selected, BMD-associated variants were &#xD;
genotyped by quantitative real-time PCR (i.e., TaqMan® fluorogenic 5’ nuclease allelic &#xD;
discrimination assay or kompetitive allele specific PCR [KASPTM]) in 1,045 postmenopausal &#xD;
women from the MOFS collection to replicate findings from literature. The SOST ECR5 &#xD;
region was also sequenced using Sanger sequencing in a subset of the individuals with extreme &#xD;
bone phenotypes (i.e., normal to high bone mass, and low bone mass; n = 212) from the MOFS &#xD;
collection, which identified two variants that were subsequently tested in the entire collection.&#xD;
Genotype-phenotype associations were assessed using the Kruskal-Wallis and Mann-Whitney &#xD;
U tests, whereas exposure odds ratios were computed using logistic regression adjusted for &#xD;
confounders. Genotype and allele frequencies of all genotyped variants were in line with &#xD;
European non-Finnish population from gnomAD. Results showed that the homozygous &#xD;
alternative genotype for WNT16 rs142005327 exerted a protective effect on LS BMD (adj-OR: 0.3 [95% CI 0.2-0.7], p=0.003) FN BMD (adj-OR: 0.5 [95% CI 0.3-0.8], p=0.009), all type of low trauma fractures (adj-OR: 0.5 [95% CI 0.3-0.9], p=0.023), and wrist fractures &#xD;
(adj-OR: 0.4 [95% CI 0.1-0.9], p=0.036), together with higher sALP levels (adj-OR: 1.9 [95% &#xD;
CI 1.1-3.3], p=0.027). SOST rs4792909 exhibited a deleterious effect on FN BMD (sBMD &#xD;
GT p=0.012; T-score GT p=0.010), and TH BMD (sBMD GT p=0.021; T-score GT &#xD;
p=0.019), while SOST rs8064375 exhibited a deleterious effect on LS BMD (T-score GA&#xD;
p=0.045). To date, this is the first study linking SOST rs8064375 with BMD. Haplotypes for &#xD;
DKK1 variants were found associated with FN BMD, while WNT16 and SOST haplotypes &#xD;
were associated with LS and FN BMD, and fracture risk. The results showcase the potential &#xD;
role of these variants as genetic determinants of BMD and fractures in Malta, further &#xD;
highlighting the importance of the WNT/β-catenin pathway in bone and pathophysiology.
Description: M.Sc.(Melit.)</description>
      <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/120171</guid>
      <dc:date>2023-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The genetics of hypermobile Ehlers-Danlos syndrome : a local study</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/119532</link>
      <description>Title: The genetics of hypermobile Ehlers-Danlos syndrome : a local study
Abstract: Background: The Ehlers-Danlos Syndromes (EDS) are a collection of thirteen rare hereditary &#xD;
connective tissue disorders which present with heterogeneous phenotypes. The commonest and &#xD;
less severe subtype, hypermobile Ehlers-Danlos Syndrome (hEDS), presents a vast spectrum &#xD;
of signs and symptoms, including extensive joint hypermobility, musculoskeletal instability, &#xD;
chronic pain and autonomic dysfunction. To date, various international research efforts failed &#xD;
to uncover its molecular genetic aetiology, and this is further confounded by inter-familial &#xD;
genetic heterogeneity.&#xD;
Aims: This original local research study sought to elucidate the genetic aetiology of hEDS in &#xD;
a small group of hEDS patients in Malta and to determine the effect of hEDS on bone mass.&#xD;
Methodology: A multigenerational Maltese family as well as an unrelated participant were &#xD;
recruited. High-throughput sequencing was performed on selected participants using Illumina &#xD;
technology. Genetic analysis was also supplemented with bone mineral density (BMD) scans &#xD;
and testing of serum bone-related analytes.&#xD;
Results: Two research participants had low bone mass and were classified as osteopenic, while &#xD;
serum levels of bone-related analytes were within the physiological range except in one &#xD;
osteopenic participant. Sequencing data was filtered using an in-house filtering pipeline to &#xD;
obtain a list of genetic variants found segregating with the disease phenotype in the family. &#xD;
This yielded five single nucleotide variants, namely TNXB rs61746206 (c.745G&gt;A, &#xD;
p.Glu249Lys), TNXB rs140304758 (c.6973G&gt;A, p.Val2325Ile), SMAD3 rs189286879 &#xD;
(c.206+32287G&gt;A), FANCA/ZNF276 rs201316239 (n.47G&gt;A) and PNPLA1 rs45524833 &#xD;
(c.745G&gt;A, p.Glu249Lys), which were not detected in the un-related participant. These &#xD;
variants were further annotated using gene databases and in-silico prediction tools to determine &#xD;
their clinical relevance.&#xD;
Discussion: None of these variants was found to be pathogenic, thus highlighting the need for &#xD;
further research on larger cohorts and families of hEDS patients. The discovery of a potentially &#xD;
causative genetic pathogenic variation will enable the establishment of an early diagnosis and &#xD;
appropriate clinical management of this multisystemic hereditary disorder.
Description: M.Sc. Biomed. Sc.(Melit.)</description>
      <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/119532</guid>
      <dc:date>2023-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Unravelling the globin gene switch mechanism in patients with hereditary persistence of foetal haemoglobin</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/119531</link>
      <description>Title: Unravelling the globin gene switch mechanism in patients with hereditary persistence of foetal haemoglobin
Abstract: Haemoglobinopathies are widely recognised as one of the most common monogenic &#xD;
diseases globally, representing a significant global health issue. Hereditary persistence of &#xD;
foetal hemoglobin (HPFH) is a benign genetic condition characterised by continuous &#xD;
production of high levels of foetal hemoglobin (HbF) throughout adulthood, resulting from &#xD;
disrupted globin gene switching. Clinical investigations and molecular findings have &#xD;
demonstrated that the presence of HPFH in conjunction with other haemoglobinopathies &#xD;
reduces the severity of associated symptoms, attributed to elevated levels of HbF. This &#xD;
study focused on three Maltese families, encompassing 11 individuals affected by HPFH &#xD;
due to a truncation mutation (p.K288X) in the KLF1 gene and 11 healthy relatives serving &#xD;
as controls. The primary objective was to gain insights into the underlying genetic and &#xD;
molecular mechanisms involved in the regulation of globin gene switching. Whole genome &#xD;
sequencing (WGS) was performed using DNA extracted from 11 affected individuals and &#xD;
9 healthy controls. A total of 205 unique variants following a dominant inheritance pattern &#xD;
were identified and found to be present in all affected individuals. All these variants were &#xD;
discovered to be located on chromosome 19 in close proximity to the KLF1 gene. &#xD;
Furthermore, novel variants were discovered in the LMO2 and KLF1 genes, which &#xD;
potentially contribute to the onset of HPFH. A subset analysis focusing on four subjects &#xD;
from Fam F1, exhibiting the highest HbF levels (&gt;3%), revealed variants in the NLRP3&#xD;
gene and in the RPS9 gene when following autosomal dominant and recessive inheritance &#xD;
patterns, respectively. These variants likely account for the sustained elevation of HbF &#xD;
levels in Fam F1, despite carrying the same KLF1 mutation as other families. Flow &#xD;
cytometry data analysis confirmed the role of KLF1 in the regulation of antigen &#xD;
expression, as individuals with HPFH exhibited reduced levels of BCAM, CD44, and P1 &#xD;
antigens on erythrocytes. Furthermore, analysis of globin gene mRNA expression, revealed&#xD;
that healthy controls had elevated mRNA levels of adult α-, β-globin genes, while &#xD;
individuals with HPFH exhibited higher mRNA levels of the fetal Aγ-globin gene. &#xD;
Proteomic analysis using mass spectrometry (MS) supported these findings and &#xD;
additionally identified 53 proteins significantly correlated with HbF levels in HPFH-affected subjects, suggesting their involvement in globin gene regulation. In conclusion, &#xD;
this study highlights the importance of adapting an integrative approach to understand the &#xD;
molecular mechanisms underlying KLF1 deficiency. The identification of potentially &#xD;
causal variants associated with HPFH, provides valuable insights into the onset of this &#xD;
condition. Further investigations involving functional work to confirm the precise impact &#xD;
of these variants, as well as the role of the identified proteins in the upregulation of HbF &#xD;
levels, can provide a more comprehensive understanding of the underlying genetic &#xD;
architecture of HPFH.
Description: M.Sc. Biomed. Sc.(Melit.)</description>
      <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/119531</guid>
      <dc:date>2023-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Identifying a genetic association between non-autoimmune diabetes &amp; bone mass</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/119530</link>
      <description>Title: Identifying a genetic association between non-autoimmune diabetes &amp; bone mass
Abstract: Introduction &amp; Aim: Diabetes and osteoporosis are two common complex diseases that have a &#xD;
strong genetic and environmental component. The genetics of these diseases have been widely &#xD;
studied separately but not as extensively together. This project aims to elucidate the genetics &#xD;
underlying non-autoimmune diabetes and bone mineral density (BMD) through two study &#xD;
approaches; whole exome sequencing (WES) in cases with suspected monogenic diabetes &#xD;
participants and genotyping of two large collections of five literature derived variants.&#xD;
Methods: Five variants derived from the literature associated with both diabetes and BMD &#xD;
were selected for replication in two Maltese case-control studies (MOFS, n = 1174 and T2D, n&#xD;
= 773 collections). Ten non-obese probands with atypical non-autoimmune diabetes diagnosed &#xD;
before the age of 40 years were recruited. Lifestyle, biochemical data and BMD measurements &#xD;
were obtained and WES was carried out to identify possibly deleterious variants.&#xD;
Results: Significant associations between the five genotyped variants and bone and T2D &#xD;
phenotypes were observed, the most notable being within TNFRSF11B rs4876868, whereby the &#xD;
alternative allele was both deleterious for BMD at the TH and LS, and protective for T2D. The &#xD;
alternative allele of variant ADCY5 rs56371916 also appeared to increase fracture risk whilst &#xD;
increasing BMD at the LS and TH, indicating a possible alteration of bone microarchitecture. A &#xD;
polygenic risk score indicated that the five genotyped variants had a negative correlation with &#xD;
HOMA-IR in individuals without T2D and a positive correlation with BMI and HDL-c in T2D &#xD;
individuals. WES of ten probands identified a total of sixteen SNVs and InDels with a possible &#xD;
association with BMD, T2D or both. A missense variant in the GCK gene (c.1364T&gt;A), was &#xD;
identified in one participant with accompanying osteoporosis at the LS, hinting at a potential &#xD;
detrimental effect on bone mass. Two participants also carried a rare frameshift variant in &#xD;
the WRAP53 gene (c.18_19delTC), indicating a likely association with T2D.&#xD;
Conclusion: A genetic link between BMD and T2D was established in literature derived variants &#xD;
and sixteen potentially pathogenic variants are identified through WES. Further confirmatory &#xD;
and functional studies for the shortlisted variants identified through WES are necessary in order &#xD;
to fully elucidate their effect on these two complex diseases.
Description: M.Sc. Biomed. Sc.(Melit.)</description>
      <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/119530</guid>
      <dc:date>2023-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

